TABLE 3.
Case No. | References | Specimen Type | LN maximum Dimension (mm) | Tumor Burden (%) | Infiltration Pattern |
---|---|---|---|---|---|
1 | Aladily11 | Excision | 20 | 70 | S, P, I, D |
2 | Alobeid et al16 | Excision | 11.8 | 5 | S, P, I |
3 | Aladily11 | Excision | 25 | 5 | S, P, I |
4 | Clemens et al5 | Dissection | 40 | 60 | S, P, I, D |
5 | Miranda et al3 | Excision | 17 | 5 | HL-like |
6 | George17 | Excision | 8.9 | 30 | S, P, I |
7 | Estes et al18 | Excision | 51 | 10 | S |
8 | Miranda et al3 | Dissection | 13 | 30 | S, I, D, NSHL-like |
9 | Unpublished | Excision | NA | 1 | S |
10 | Clemens et al5 | Dissection | 21 | 95 | S, P, I, D |
11 | Acevedo-Banez et al19 | Needle bx | 12 | 20 | S, I |
12 | Tardio and Granados20 | Dissection | 29 | 5 | S, P, I |
13 | Laurent et al21 | Dissection | 25 | 10 | S, I |
14 | Unpublished | Dissection | 12 | 5 | S, I |
Reactive features |
|||||
Cytomorphology | Hallmark Cells | Follicular Hyperplasia | Sinus Histiocytosis | Paracortical Hyperplasia | Eosinophils |
Oval, lobated, anaplastic | Yes | Yes | Yes | Yes | Yes |
Oval | No | Yes | No | Yes | Yes |
Oval, lobated | Yes | Yes | No | No | Yes |
Oval | No | Yes | Yes | No | Yes |
Oval | No | Yes | Yes | Yes | Yes |
Oval, anaplastic | Yes | Yes | Yes | No | Yes |
Oval, lobated | Yes | Yes | Yes | No | Yes |
Oval, lobated | No | Yes | Yes | Yes | Yes |
Lobated | No | Yes | Yes | No | No |
Oval, lobated | No | Yes | No | No | Yes |
Oval, lobated | Yes | No | No | No | Yes |
Lobated, anaplastic | Yes | Yes | Yes | Yes | No |
Lobated | Yes | Yes | No | No | Yes |
Oval | No | Yes | Yes | Yes | Yes |
D indicates diffuse; I, interfollicular; NSHL-like, nodular sclerosis Hodgkin lymphoma-like; HL-like, Hodgkin lymphoma-like (excludes NSHL-like); LN, Lymph node; P, perifollicular; S, sinusoidal.